Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial

Journal:

Journal of Hepatology

Published:

2025-05-11

DOI:

10.1016/j.jhep.2025.04.025

Affiliations:

47

Authors:

42

Go to article

Institutions	Authors	Share
Ipsen Group, France	2.000000	0.05
Ipsen USA, United States of America (USA)	2.000000	0.05
Ipsen Bioinnovation, United Kingdom (UK)	2.000000	0.05
Jefferson University Hospitals, TJU, United States of America (USA)	1.000000	0.02
Hull University Teaching Hospitals NHS Trust, United Kingdom (UK)	1.000000	0.02
Aspen Woods Clinic, Canada	1.000000	0.02
Charité - University Medicine Berlin, Germany	1.000000	0.02
Clínica Universitária de Gastrenterologia, ULISBOA, Portugal	1.000000	0.02
The University of British Columbia (UBC), Canada	1.000000	0.02
University of Miami Health System (UHealth), United States of America (USA)	1.000000	0.02
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	1.000000	0.02
University Hospital of Modena, Italy	1.000000	0.02
Bon Secours Mercy Health, United States of America (USA)	1.000000	0.02
IRCCS Casa Sollievo della Sofferenza Hospital, Italy	1.000000	0.02
Queen Mary University of London (QMUL), United Kingdom (UK)	1.000000	0.02
La Paz University Hospital, UAM, Spain	1.000000	0.02
University of Colorado Health (UCHealth), United States of America (USA)	1.000000	0.02
William Osler Health System, Canada	1.000000	0.02
NYU Langone Health, United States of America (USA)	1.000000	0.02
University of Maryland, Baltimore (UMB), United States of America (USA)	1.000000	0.02
University Hospital Frankfurt, GU, Germany	1.000000	0.02
Liver Institute Northwest, United States of America (USA)	1.000000	0.02
UC Davis Health, United States of America (USA)	1.000000	0.02
Queen Elizabeth University Hospital Glasgow, United Kingdom (UK)	1.000000	0.02
University Hospital Montecelo, Spain	1.000000	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.02
South Denver Gastroenterology, P.C., United States of America (USA)	1.000000	0.02
University of Nebraska Medical Center (UNMC), United States of America (USA)	1.000000	0.02
Intermountain Healthcare, United States of America (USA)	1.000000	0.02
Aberdeen Royal Infirmary, NHS Grampian, United Kingdom (UK)	1.000000	0.02
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	1.000000	0.02
University of Alberta (U of A), Canada	1.000000	0.02
Virginia Commonwealth University (VCU), United States of America (USA)	1.000000	0.02
Frimley Health NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
AdventHealth, United States of America (USA)	0.500000	0.01
Rocky Mountain Gastroenterology (RMG), United States of America (USA)	0.500000	0.01
NIHR Birmingham Biomedical Research Centre, United Kingdom (UK)	0.500000	0.01
University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK)	0.500000	0.01
UCL, United Kingdom (UK)	0.500000	0.01
Royal Free Hospital, United Kingdom (UK)	0.500000	0.01
University of Padova (UNIPD), Italy	0.333333	0.01
Azienda Ospedaliera di Padova, Italy	0.333333	0.01
ERN RARE-LIVER, Italy, Italy	0.333333	0.01
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain	0.333333	0.01
Gregorio Marañon University Hospital, Spain	0.333333	0.01
Complutense University of Madrid (UCM), Spain	0.333333	0.01

Interested in Clinical Sciences?